Vagus Nerve Stimulation as Treatment for Long Covid

Sex: All

Ages: N/A – 70 Years

Phase: NA

Enrollment: 16

Sponsor: Icahn School of Medicine at Mount Sinai

Summary

Many patients do not recover following Covid infection. The resulting illness is called Long Covid. Because there is no agreed upon treatment for this ailment, the research team has decided to do an open label pilot study using non-invasive, transcutaneous stimulation of the auricular branch of the vagus nerve. Inclusion criteria required the patient to fulfill criteria for having chronic fatigue syndrome. To date, fourteen patients provided evaluable data. Eight of these fulfilled the study's requirements for treatment success.

Eligibility Criteria

Inclusion Criteria:Patients had to have had COVIDPatients have to fulfill the 1994 case definition for chronic fatigue syndrome.Exclusion Criteria:BMI > 30

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05608629). StuddyBuddy aggregates publicly available trial information.